The AKZOF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AKZOF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AKZOF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AKZOF Detailed Price Forecast - CNN Money||View AKZOF Detailed Summary - Google Finance|
|View AKZOF Detailed Summary - Yahoo! Finance||View AKZOF Stock Research & Analysis - Zacks.com|
|View AKZOF Trends & Analysis - Trade-Ideas||View AKZOF Major Holders - Barrons|
|View AKZOF Call Transcripts - NASDAQ||View AKZOF Breaking News & Analysis - Seeking Alpha|
|View AKZOF Annual Report - CompanySpotlight.com||View AKZOF OTC Short Report - OTCShortReport.com|
|View AKZOF Fundamentals - TradeKing||View AKZOF SEC Filings - Bar Chart|
|View Historical Prices for AKZOF - The WSJ||View Performance/Total Return for AKZOF - Morningstar|
|View the Analyst Estimates for AKZOF - MarketWatch||View the Earnings History for AKZOF - CNBC|
|View the AKZOF Earnings - StockMarketWatch||View AKZOF Buy or Sell Recommendations - MacroAxis|
|View the AKZOF Bullish Patterns - American Bulls||View AKZOF Short Pain Metrics - ShortPainBot.com|
|View AKZOF Stock Mentions - StockTwits||View AKZOF Stock Mentions - PennyStockTweets|
|View AKZOF Stock Mentions - Twitter||View AKZOF Investment Forum News - Investor Hub|
|View AKZOF Stock Mentions - Yahoo! Message Board||View AKZOF Stock Mentions - Seeking Alpha|
|View Insider Transactions for AKZOF - SECform4.com||View Insider Transactions for AKZOF - Insider Cow|
|View AKZOF Major Holdings Summary - CNBC||View Insider Disclosure for AKZOF - OTC Markets|
|View Insider Transactions for AKZOF - Yahoo! Finance||View Institutional Holdings for AKZOF - NASDAQ|
|View AKZOF Stock Insight & Charts - FinViz.com||View AKZOF Investment Charts - StockCharts.com|
|View AKZOF Stock Overview & Charts - BarChart||View AKZOF User Generated Charts - Trading View|
Wall Street Wins Its High Stakes Bet on Akzo Nobel Buyout
Posted on Friday September 21, 2018
The decision of a group of Wall Street banks to underwrite the buyout financing for Akzo Nobel NV chemicals unit paid off, with the 6.4 billion-euro ($7.5 billion) debt sale wrapping up this week after attracting overwhelming demand. Barclays Plc, HSBC Holdings Plc and JPMorgan Chase & Co. earlier this year committed to fund Carlyle Group LP’s $12.5 billion acquisition of the Akzo Nobel business at a time when the leveraged finance market was burning hot.
Akzo Nobel loans break for trading
Posted on Thursday September 20, 2018
The US$6.44bn in term loans backing Carlyle Group and Singaporean wealth fund GIC’s acquisition of Akzo Nobel’s chemicals business allocated and broke for trading on Thursday. The US$4.34bn seven-year term loan B broke at 100.375-100.75 on Thursday, while the US$2.1bn-equivalent euro-denominated facility broke at 100.5-101. Pricing on the US$4.34bn term loan B was finalized at 325bp plus Libor, tightened from earlier guidance of 350bp-375bp range and 400bp-425bp range at launch.
Envision’s $5.05 billion loan marks jumbo buyout trio
Posted on Thursday September 20, 2018
The $5.05 billion (3.81 billion pounds) term loan for Envision Healthcare is the third massive leveraged loan to hit the market since September and also looks set to benefit from huge institutional demand which has already seen multibillion buyout loans for Thomson Reuters’ F&R business, Refinitiv, and Akzo Nobel’s Specialty Chemicals business successfully placed. Envision’s loan will bring the total of jumbo loans syndicated since early September to US$20.7bn, in addition to the US$9.25bn loan for Refinitiv and Akzo Nobel’s US$6.44bn loan. Although the commitment deadline for Envision’s loan is October 1, the deal is already fully subscribed and is expected to tighten in line with the two previous jumbo deals, bankers said.
Biggest Buyout Financings Steamroll Over Investor Safeguards
Posted on Wednesday September 12, 2018
The year’s biggest buyout financing, backing the $20 billion acquisition of Thomson Reuters Corp.’s spinoff, Refinitiv, is challenging some hard-won investor protections. The deals are bucking a trend of investor pushback in Europe this year. In recent months power has shifted back in favor of high-yield investors, particularly in Europe, where at least 11 deals have either been delayed or withdrawn so far this year, and swathes of transactions that priced were heavily amended.